What to watch with CYP2C19 and allergy?

CYP2C19 is a key drug-metabolizing enzyme in the CYP450 system, responsible for breaking down drugs like proton pump inhibitors, clopidogrel, and some antidepressants. Regarding allergies, CYP2C19 could theoretically influence the metabolism of certain antihistamines or corticosteroids, but clinical evidence is weak. Most common antihistamines (e.g., cetirizine, loratadine) are not primarily metabolized by CYP2C19. Some newer antihistamines or corticosteroids may be affected, but studies are lacking. The provided context contains no specific information linking CYP2C19 to allergy. Consumer DNA tests often report CYP2C19 phenotypes (e.g., poor metabolizer), but relevance to allergy medications is unclear. Caution: Do not adjust medications without consulting a physician. Evidence grade: unclear/mechanistic.